Johnston T P, McCaleb G S, Montgomery J A
J Med Chem. 1975 Jun;18(6):634-7. doi: 10.1021/jm00240a026.
N-(2-chloroethyl)-N'-(cis-4-hydroxycylohexyl)-N-nitrosourea, a major metabolite of N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea (CCNU), and its trans isomer were prepared from the corresponding 4-aminocyclohexanols. A convenient and stereospecific precursor was found in 2-oxa-3-azabicyclo[2.2.2]oct-5-ene hydrochloride, hydrogenation giving pure cis-4-aminocyclohexanol hydrochloride. The metabolites were, at nontoxic levels, at least as active as CCNU in tests against murine leukemia L1210 implanted both intraperitoneally and intracerebrally and, on a weight basis, were more active and more toxic. These observations and previously reported metabolic studies suggest that the anticancer activity of CCNU is due primarily to its metabolites.
N-(2-氯乙基)-N'-(顺式-4-羟基环己基)-N-亚硝基脲,N-(2-氯乙基)-N'-环己基-N-亚硝基脲(CCNU)的一种主要代谢产物,及其反式异构体由相应的4-氨基环己醇制备而成。在2-氧杂-3-氮杂双环[2.2.2]辛-5-烯盐酸盐中发现了一种便捷的立体特异性前体,氢化后可得到纯的顺式-4-氨基环己醇盐酸盐。在针对腹腔内和脑内植入的小鼠白血病L1210的试验中,这些代谢产物在无毒剂量下至少与CCNU活性相当,且按重量计算,活性更高、毒性更大。这些观察结果以及先前报道的代谢研究表明,CCNU的抗癌活性主要归因于其代谢产物。